Recruiting Lung Cancer Studies in Porto Alegre
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
This study will evaluate the efficacy of two dosing regimens of adagrasib (600 mg BID versus 400 mg BID) in patients with NSCLC with KRAS G12C mutation....
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
The objective of this study is to evaluate the efficacy and/or safety of multiple therapies in patients with early-stage resectable NSCLC. Cohort B1 is a phase II cohort that will evaluate the safety,...
About Lung Cancer Clinical Trials in Porto Alegre
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Porto Alegre, RIO%20GRANDE%20DO%20SUL. These studies are seeking a combined 350 participants. Research is being sponsored by Mirati Therapeutics Inc., Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Porto Alegre — FAQ
Are there lung cancer clinical trials in Porto Alegre?
Yes, there are 2 lung cancer clinical trials currently recruiting in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Porto Alegre?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Porto Alegre research site will contact you about next steps.
Are clinical trials in Porto Alegre free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Porto Alegre studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Porto Alegre are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov